Berlin

Product Overview

Caberlin is a pharmaceutical preparation containing Cabergoline as its active component. This medication falls under the category of dopamine agonists, primarily utilized for managing conditions associated with excessive prolactin production.

Therapeutic Applications

This medication is predominantly indicated for treating hyperprolactinemia – a hormonal disorder marked by abnormally high prolactin levels in the bloodstream. Additionally, it serves as an effective therapeutic option for managing prolactin-secreting pituitary adenomas (prolactinomas).

Administration Guidelines

Caberlin tablets should be taken orally, with the option of consuming them with or without meals. Patients must adhere strictly to the prescribed dosing regimen. The tablets should be swallowed whole without crushing, chewing, or breaking to maintain their controlled-release properties.

Mechanism of Action

The active constituent Cabergoline exerts its pharmacological effect by selectively activating dopamine receptors in the central nervous system. Through its dopaminergic activity, this compound effectively suppresses prolactin secretion from the anterior pituitary gland.

Dosing Protocol

The appropriate dosage of this medication is determined by the treating physician based on individual patient factors and therapeutic response. Treatment typically commences with a conservative dose, which may be progressively adjusted under medical supervision to achieve optimal clinical outcomes.

Therapeutic Advantages

• Significantly reduces circulating prolactin concentrations
• Alleviates clinical manifestations of hyperprolactinemia including menstrual irregularities, fertility issues, and inappropriate lactation
• Demonstrates efficacy in controlling prolactinoma progression, thereby preventing tumor-related complications

Frequently Reported Adverse Effects

Patients may experience transient gastrointestinal disturbances (nausea, abdominal discomfort), neurological symptoms (dizziness, headaches), or general malaise (fatigue). While these reactions are typically self-limiting, persistent or severe symptoms warrant medical consultation.

Important Precautions

• Contraindicated in patients with pre-existing valvular heart disease or fibrotic conditions
• Disclose all concomitant medications, including over-the-counter products and herbal supplements, to your healthcare provider
• Exercise caution when engaging in activities requiring mental alertness, as this medication may induce drowsiness or vertigo

Proper Storage Conditions

Maintain Caberlin in its original packaging at controlled room temperature, protected from humidity and direct sunlight. Ensure secure storage away from children and household pets. Avoid storing in moisture-prone areas such as bathrooms. Dispose of expired or unused medication following appropriate pharmaceutical waste protocols.

Medical Disclaimer:

The content provided herein is intended for educational purposes only and represents carefully vetted, scientifically validated information. However, this material should not supersede professional medical advice, diagnosis, or treatment. The complete safety profile, potential drug interactions, and contraindications may not be fully enumerated. We strongly advise consulting with qualified healthcare providers regarding any medical condition or therapeutic regimen. This information aims to facilitate informed patient-physician discussions rather than replace them.